Managing a portfolio of interdependent new product candidates in the pharmaceutical industry

被引:132
|
作者
Blau, GE [1 ]
Pekny, JF
Varma, VA
Bunch, PR
机构
[1] Purdue Univ, Dept Chem Engn, W Lafayette, IN 47908 USA
[2] Lilly Res Labs, Indianapolis, IN USA
关键词
D O I
10.1111/j.0737-6782.2004.00075.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Highly regulated industries such as pharmaceuticals and agrochemicals face the challenge of maintaining a Ocontinuous stream of new products. This is difficult because of low probabilities of technical success, high development costs, uncertain market impact, a scarcity of good new product ideas, and limited human and capital resources available to develop them. The problem of evaluating and selecting which new products to develop and then of sequencing or of scheduling them is complicated further by the presence of dependencies between products both in the market place and in the development process itself. This study proposes a portfolio management approach that selects a sequence of projects, which maximizes the expected economic returns at an acceptable level of risk for a given level of resources in a new product development pipeline. A probabilistic network model of distinct activities is used to capture all the activities and resources required in the "process" of developing a new drug. A prioritization scheme suggesting sequences for developing new independent drug candidates with unlimited resources is generated with a conventional bubble chart approach. These sequences initiate a genetic algorithm (GA)-based search for the optimal sequence in the presence of product dependencies and limited resources. By statistically evaluating the sequences generated during the GA search using a discrete event simulation model, it is possible to construct an economic reward-risk frontier that illustrates the trade-offs between expected rewards and risks. The model ideally is suited to answer various "what if" questions relative to changes in the resource level on pipeline performance. The methodology is illustrated with an industrially motivated case study, involving nine interdependent new product candidates targeting three diseases. The dramatic results yield a candidate sequence with an expected return 28 percent higher than the sequence suggested by the bubble chart approach at almost the same level of risk. The synergism among the candidate dependencies, pipeline resources, and economic and technical uncertainties demonstrates the necessity of a computationally intensive approach if the best development strategy is to be realized.
引用
收藏
页码:227 / 245
页数:19
相关论文
共 50 条
  • [21] Managing new product development in the Chinese steel industry: an empirical investigation
    Huang, XL
    Steffens, P
    Schroder, B
    INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 2002, 24 (5-6) : 557 - 568
  • [22] MINGLING INTRA-PORTFOLIO COMPETITION WITH BRAND PORTFOLIO STRATEGY: A STUDY OF PHARMACEUTICAL INDUSTRY
    Ayub, Arslan
    Shabbir, Rizwan
    Kiran, Faiqa
    Zubair, Ahsan
    Abbas, Aamir
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 11087 - 11095
  • [23] A theoretical framework for managing the new product development portfolio: When and how to use strategic buckets
    Chao, Raul O.
    Kavadias, Stylianos
    MANAGEMENT SCIENCE, 2008, 54 (05) : 907 - 921
  • [24] Challenges in Decision-Making Modelling for New Product Development in the Pharmaceutical Industry
    Marques, Catarina M.
    Moniz, Samuel
    de Sousa, Jorge Pinho
    29TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, PT B, 2019, 46 : 1411 - 1416
  • [25] New product development process and time-to-market in the generic pharmaceutical industry
    Prasnikar, Janez
    Skerlj, Tina
    INDUSTRIAL MARKETING MANAGEMENT, 2006, 35 (06) : 690 - 702
  • [26] NEW-PRODUCT SUCCESS IN THE PHARMACEUTICAL INDUSTRY: HOW MANY BITES AT THE CHERRY?
    Corstjens, Marcel
    Demeire, Edouard
    Horowitz, Ira
    ECONOMICS OF INNOVATION AND NEW TECHNOLOGY, 2005, 14 (04) : 319 - 331
  • [27] Managing a Portfolio of Product Development Projects under Resource Constraints
    Browning, Tyson R.
    Yassine, Ali A.
    DECISION SCIENCES, 2016, 47 (02) : 333 - 372
  • [28] Close Loop Supply Chains: Managing Product Recovery Portfolio
    Amaro, A. C. S.
    Barbosa-Povoa, A. P. F. D.
    16TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING AND 9TH INTERNATIONAL SYMPOSIUM ON PROCESS SYSTEMS ENGINEERING, 2006, 21 : 1875 - 1880
  • [29] Managing New Product Development in the Fashion Industry with PLM: Based on Market Classifications
    Sullivan, Brendan Patrick
    Rossi, Monica
    Athavale, Sameer
    Fani, Virginia
    Bindi, Bianca
    Ferraris, Luca
    Bandinelli, Romeo
    Terzi, Sergio
    PRODUCT LIFECYCLE MANAGEMENT: GREEN AND BLUE TECHNOLOGIES TO SUPPORT SMART AND SUSTAINABLE ORGANIZATIONS, PT I, 2022, 639 : 167 - 178
  • [30] AN ANTITRUST ANALYSIS OF PRODUCT HOPPING IN THE PHARMACEUTICAL INDUSTRY
    Cheng, Jessie
    COLUMBIA LAW REVIEW, 2008, 108 (06) : 1471 - 1515